Resnick Paul F 4
4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Jan 18, 2018
Insider Transaction Report
Form 4
Resnick Paul F
Vice President, CBO
Transactions
- Sale
Common Stock
2018-01-16$0.92/sh−3,071$2,825→ 18,333 total
Footnotes (2)
- [F1]Represents a portion of the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II of the reporting person. This sale is mandated by the Issuer's election under the equity incentive plan to require satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $1.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.